Core Insights - West Pharmaceutical Services, Inc. will release its third-quarter financial results on October 23, 2025, before market opening, followed by a conference call at 8:00 a.m. Eastern Time to discuss the results and business expectations [1][2]. Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting both established and emerging drug developers [3]. - The company has over 10,000 team members across 50 sites, including 25 manufacturing facilities worldwide, delivering over 41 billion components and devices annually [3]. - In fiscal year 2024, West generated $2.89 billion in net sales and is traded on the New York Stock Exchange (NYSE: WST), being part of the Standard & Poor's 500 index [4].
West to Host Third-Quarter 2025 Conference Call